Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($5.61), $5.48 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• BNP Paribas Exane Upgrades Novonesis A/S (NSISB:DC) to Neutral
• JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight